NCT04124952View on ClinicalTrials.gov

Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

February 16, 2021

Study Completion Date

February 16, 2021

Conditions
Cataract
Interventions
DEVICE

Panoptix

Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)

Trial Locations (1)

33323

SightTrust Eye Institute, Sunrise

All Listed Sponsors
collaborator

Science in Vision

OTHER

lead

SightTrust Eye Institute

OTHER

NCT04124952 - Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens | Biotech Hunter | Biotech Hunter